Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Actually, the large or `meaningful trades`are lower ; - (

View:

Post by SouthernTierTom on Dec 28, 2021 10:50am

Actually, the large or `meaningful trades`are lower ; - (

Recent Trades - Last 10 of 12

Time ET	Ex	Price	Change	Volume
10:14:51	Q	0.2882	0.0232	1,409
10:14:51	Q	0.2882	0.0232	2,500
10:13:25	Q	0.288	0.023	791
10:02:06	Q	0.263	-0.002	15,209
09:58:21	Q	0.25835	-0.00665	265
09:56:28	Q	0.263	-0.002	50,000
09:52:44	Q	0.296	0.031	100
09:46:01	Q	0.24	-0.025	2,500
09:46:01	Q	0.24	-0.025	3,814
09:46:01	Q	0.268	0.003	2,68

427

Comment

Comment by SouthernTierTom on Dec 28, 2021 11:36am

Here you go bluefranks.. Looks like more of the same with volume pushing it lower and meaningless tiny trades changing the color! Recent Trades - Last 10 of 19 Time ET Ex Price Change Volume 10:50:21 Q 0.2775 0.0125 200 10:44:27 Q 0.252 -0.013 ...more

425

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password